Corporate Social Responsibility (CSR) is important to us

We are committed to building a sustainable and socially responsible biotech. We believe that our actions should benefit our stakeholders and society as a whole. Being socially responsible is fundamental to the way we do business.

Nykode Therapeutics’ commitment to CSR is anchored in our company’s purpose, values and vision. We are dedicated to building a sustainable organization that meets environment, social and governance (ESG) criteria that are relevant to our business operations.


The primary focus of Nykode’s corporate social responsibility (CSR) efforts is its employees. The Company has no formal policy on CSR but adheres to a set of guidelines in its Code of Conduct regarding employee health and safety, and conduct toward healthcare professionals, vendors and competitors.

There were no accidents or work-related injuries during the reporting period. The sick-leave rate of absence was 3.1% in 2020.

Environment and Climate

Nykode may use hazardous materials in its laboratories and has put in place routines to handle such materials in a way that minimizes the impact on the environment. However, as the Company operates from rented facilities where services for the proper handling and disposal of hazardous materials are readily available and conducts its business in a highly regulated industry, Nykode’s potential impact on the environment and climate is viewed as minimal. In other words, the Company does not pollute the environment. As a result, specific environment and climate policies have not currently been adopted.

Business Ethics

Nykode, in collaboration with its partners, conducts preclinical experiments in animals as well as clinical trials. The animal experiments are approved by the Norwegian governing body Mattilsynet. Nykode only uses R&D vendors and laboratories that are approved and have documented high standards and expertise in animal research. The clinical trials are performed in accordance with the ethical and scientific principles governing clinical research on human subjects, as set out in the Declaration of Helsinki and the International Conference on Harmonization (ICH) guidelines on Good Clinical Practice. Nykode collaborates with world-leading, competent service providers that specialize in these types of studies and consults with leading experts on trial design to optimize trial conduct. Procedures for handling personal data in accordance with the General Data Protection Regulation (GDPR) have been implemented.

Nykode is committed to maintaining the highest standards of ethical conduct and will not tolerate the use of bribery or corruption to achieve its business objectives. The Company has established anti-corruption policies according to which all employees must decline any expensive gifts, money, trips or other such offerings from business contacts. The Company is working to apply these guidelines with its suppliers.

No incidents of bribery or whistleblowing were reported in 2020.